Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name LOC554202
   Synonyms MIR31HG, hsa-lnc-31, LncHIFCAR, LOC554202
   Region GRCh38_9:21455642-21559669    Sequence
   Ensembl ENSG00000171889
   RefSeq NR_027054
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name lung adenocarcinoma
   ICD-0-3 C34  M8140/3
   Methods qPCR, in vitro knockdown etc.
   Sample cell lines (A549, H2228, H1975,H1299), lung adenocarcinoma tissue
   Expression Pattern up-regulated
   Function Description

MIR31HG was highly expressed in lung adenocarcinoma tissues and cell lines,and associated with clinical staging, N classification,M classification and differentiated degree.MIR31HG high-expression was an independent unfavorable prognostic factor for lung adenocarcinoma patients.Down-regulation of MIR31HG inhibited lung adenocarcinoma cells proliferation and blocked cell-cycle, but has no effect on cell.apoptosis.MIR31HG high-expression is an independent unfavorable prognostic factor for lung adenocarcinoma patients,and serves an oncogenic role to modulate lung adenocarcinoma cells proliferation and cell-cycle.

   Pubmed ID 29367106
   Year 2018
   Title LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma.
   External Links
   Links for  LOC554202 GenBank       HGNC       lncrnadb       Noncode
   Links for  lung adenocarcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.